Skip to main content

Advertisement

Table 2 Selected characteristics of patients in the Fred Hutchinson prostate cancer patient cohort

From: Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy

Variables Patients (n = 523)
Number Percentage (%) Mean (SD)
Age at diagnosis (years)    58.1 (7.1)
Race    
 African-American 44 8.4  
 European-American 479 91.6  
Body mass index at diagnosis (kg/m2)    26.9 (3.7)
Pathological stagea    
 Local 360 68.8  
 Regional 163 31.2  
Gleason score    
 ≤6 252 48.2  
 7(3 + 4) 188 35.9  
 7(4 + 3) 45 8.6  
 8–10 38 7.3  
PSA at diagnosis (ng/mL)b    
 0−3.9 80 16.2  
 4−9.9 313 63.5  
 10−19.9 67 13.6  
 ≥20 33 6.7  
Recurrenceb    
 No recurrence 323 74.9  
 Recurrence 108 25.1  
Follow-up time (years)b    8.0 (4.2)
  1. PSA prostate-specific antigen
  2. aLocal stage is pT2, N0/NX, M0. Regional stage is pT3-T4 and/or N1, M0
  3. bTwenty-six patients had missing data on diagnostic PSA levels, and 92 patients had missing data on recurrence. Three additional patients had missing follow-up data